Vestibular Testing System Market Outlook

The vestibular testing system market size is projected to be valued at US$ 119.3 million in 2023 and is expected to rise to US$ 202.4 million by 2033. The sales of vestibular testing systems are expected to register a significant CAGR of 5.4% during the forecast period.

Due to the low cost and convenience of the use of the VNG system, the vestibular testing system market is expected to develop during the forecast period. Private clinics and hospitals comprise the two main vestibular testing system market segments.

The vestibular testing system market share is predicted to have a large proportion of revenue in the hospital segment due to hospital infrastructure development.

Patients who have issues with their balance can be properly diagnosed with the adoption of vestibular testing systems. On the other hand, numerous recent studies have found that vestibular testing systems are more reliable than medical examinations in identifying inner ear diseases.

Attributes Details
Vestibular Testing System Market CAGR 5.4%
Vestibular Testing System Market Valuation (2023) US$ 119.3 million
Vestibular Testing System Market Valuation (2033) US$ 202.4 million

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What are the Key Drivers and Restraints of the Market?

As per the vestibular testing system market study, the industry developed at a rate of 6.9% during the last few years. Despite the pandemic, the vestibular testing system market is maintaining a CAGR of 5% during the forecast period.

Drivers:

The prevalence of vertigo and balance issues among patients globally is rising, and it is anticipated that this trend is likely to continue. Several Western European nations have reported seeing the exact same thing.

Although the patient population is expanding and techniques available for evaluating the vestibular system are growing, patients who experience vertigo frequently receive either inappropriate or insufficient treatment.

As a result, during the past few decades, there have been considerable changes in VNG test demand, vestibular test batteries, and vestibular function testing.

A significant factor driving demand for general vestibular testing, as well as clinical vestibular testing (VNG), is the rising incidence of vestibular disorders among children globally. This trend also contributes significantly to expanding the vestibular testing system market.

Restraints:

The high cost of tests and the lack of qualified specialists in comprehending test findings are some factors restraining the growth of the global vestibular testing system market.

The expenses associated with computerized dynamic post-urography (CDP) and vestibular evoked myogenic potential (VEMP) are twice as high as those associated with other treatments. In addition, the expenses related to vestibular testing are higher than those associated with physical therapy treatments.

Demand for vestibular testing systems for vertigo is also hampered by a challenging reimbursement scenario, which impedes market expansion. A significant portion of the population relies on insurance to cover the cost of their medical care. No reimbursements are available for any of the various equipment used in the vestibular testing system sector as a whole.

What Are the Trends in the Market?

Opportunities:

Improving healthcare infrastructure and an increased risk of clinically significant consequences like falls are the primary contributors to the expansion of vestibular testing systems across the world. In addition, an increase in people who have problems with their balance has led to a crucial expansion in the capabilities of vestibular testing equipment, leading to a rise in the demand for vestibular testing systems.

Threats:

Due to the lack of health insurance and government assistance programs that cover a variety of treatments in nations such as the United Kingdom and Germany, affordability is a big issue that affects the majority of the people.

One of the primary problems that is slowing down the development of the vestibular testing system market is the lack of availability of public health insurance.

In addition, taking into consideration the current environment, the vestibular testing system market is somewhat controlled by local players, which makes it difficult for insurance carriers to cover under any particular standards. It is anticipated that the growth in demand for vestibular testing systems can be negatively impacted as a result of these factors.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

2018 to 2022 Vestibular Testing System Market Outlook in Comparison to 2023 to 2033 Growth Forecast

The period from 2018 to 2022 witnessed a steady growth of 4.4% in the vestibular testing system market. During this time, the market experienced increased demand for diagnostic devices and equipment for assessing individuals' vestibular systems. Factors such as the rising prevalence of vestibular disorders, growing awareness about early diagnosis, and advancements in technology contributed to the market's positive outlook during this period.

Looking ahead, the growth forecast for the vestibular testing system market from 2023 to 2033 is even more promising. The market is expected to expand significantly during this period due to several factors. These include the aging population, which is prone to vestibular disorders, the increasing adoption of diagnostic testing for early detection and treatment, and continuous advancements in vestibular testing technology.

Furthermore, ongoing research and development activities are expected to lead to the introduction of innovative testing systems with improved accuracy and efficiency. This may further drive the market growth as healthcare providers and patients alike recognize the importance of accurate diagnosis and personalized treatment plans for vestibular disorders.

Comparative View of the Adjacent Market

Vestibular Testing System Market:

Attributes Vestibular Testing System Market
CAGR (2023 to 2033) 5.4%
Market Value (2033) US$ 202.4 million
Growth Factor The prevalence of vertigo and balance issues among patients globally is rising, and it is anticipated that this trend is likely to continue.
Opportunity The vestibular testing system market share is predicted to have a large proportion of revenue in the hospital segment due to the development of hospital infrastructure.

Self-testing Market:

Attributes Self-testing Market
CAGR (2023 to 2033) 13.6%
Market Value (2033) US$ 5.6 billion.
Growth Factor The market has grown across various product categories, including glucose monitoring, pregnancy, and fertility testing,
Opportunity Technological advancements have also helped drive market growth, with new products offering improved accuracy, reliability, and ease of use.

Kinase Inhibitors for Cancer Treatment Market:

Attributes Kinase Inhibitors for Cancer Treatment Market
CAGR (2023 to 2033) 10.5%
Market Value (2033) US$ 122,133.64 million
Growth Factor Pharmaceutical companies are currently investing heavily in R&D to develop improved kinase inhibitors. This is presently propelling the market growth.
Opportunity Massive technological advancements are taking place in the healthcare sector, particularly in the field of cancer treatment.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Country-wise Analysis

What is the Growth Outlook for the Vestibular Testing System in North America?

The United States is expected to continue enjoying substantial growth during the projection period, which should allow the vestibular testing system to maintain its dominant position in the North American area, where it is expected to hold a total market share of 34.2% in 2022.

The increasing prevalence of vestibular illnesses across the country, as well as the establishment of Medicare benefits for the utilization of vestibular testing equipment by doctors and patients, are the primary factors driving the vestibular testing system market expansion.

How is Europe performing in the Vestibular Testing System Market?

Europe is the second-leading market for vestibular testing systems in the world as a result of various research institutes and vibrant research communities. It holds a significant spot, with a market share of 30.1% for vestibular testing systems.

During the forecast period, it is anticipated that Germany is likely to continue to hold a substantial share of the European vestibular testing system market at around 9.8%. The amount spent on healthcare by individuals on a global scale is growing.

A significant shift in spending on healthcare has occurred as a direct result of people's willingness and ability to invest in their health and wellness. Modern methods are being implemented at a growing rate in the outpatient and inpatient ENT-specific sectors of the German healthcare system.

The medical benefits of contemporary diagnostic techniques, as well as their quality and efficiency, have led to a strong demand for vestibular testing goods, as has the necessity for vestibular function tests with their scientific usefulness being established.

What Is the Regional Outlook for The Vestibular Testing System Market in China?

China held a 2.3% share of the global sales of vestibular testing systems in 2020, and it is anticipated that this market may rise at a CAGR of 6.3% from 2023 to 2033. The inclusion of studies and applications for the Chinese vestibular testing system market in international publications has resulted in a broader scope of evaluation for newly developed VEMP systems in the country.

Category-wise Insights

Videonystagmography (VNG) holds a Significant Share of 52.40% in the Vestibular Testing System Market.

VNG is a diagnostic test used to evaluate the function of the vestibular system, which is responsible for maintaining balance and eye movements. It is a non-invasive and objective method that utilizes video recording and eye-tracking technology to assess various aspects of the vestibular system.

The adoption of VNG has been increasing in the market due to its effectiveness in diagnosing and monitoring vestibular disorders. VNG offers advantages such as high accuracy, reproducibility, and the ability to assess a wide range of vestibular functions, including gaze stability, positional nystagmus, and spontaneous nystagmus.

Hospitals Play a Significant Role in the Vestibular Testing System Market.

Segment to Acquire 66.80% Value Share in 2022. They are key users and providers of vestibular testing services, essential for diagnosing and managing various vestibular disorders. Vestibular testing is commonly conducted in hospitals to evaluate patients with symptoms such as vertigo, dizziness, imbalance, and related conditions. These tests help healthcare professionals identify the underlying causes of these symptoms and develop appropriate treatment plans.

Hospitals typically have specialized departments or clinics dedicated to diagnosing and treating vestibular disorders, such as Ear, Nose, and Throat (ENT) departments or Balance Centers. These facilities are equipped with advanced vestibular testing systems and employ specialized healthcare professionals, including ENT specialists, neurologists, audiologists, and technicians, who are trained in conducting and interpreting the results of vestibular tests.

Competitive Landscape

How are Start-ups Influencing the Vestibular Testing System Market?

Due to the rising potential of the vestibular testing system market, several medical device businesses have developed innovative systems. These systems open up new income pockets for existing manufacturers, expressing an opportunistic attitude to the increasing need for vestibular examinations.

How Key Players are Contributing to the Vestibular Testing System Market?

Mergers and acquisitions have emerged as a crucial growth strategy among industry leaders, particularly in light of the consolidation operations that have taken place in the vestibular testing system market. This pattern has been particularly noticeable in North America, one of the most important vestibular testing system markets.

Moreover, mergers and acquisitions in the vestibular testing system market are expected not only to serve to fortify the acquirer's existing portfolio but also to contribute to the expansion of the acquirer's presence on both the regional and the worldwide levels.

Scope of Report

Attributes Details
Forecast Period 2023 to 2033
Historical Data Available for 2018 to 2022
Market Analysis US$ million for Value
Key Countries Covered United States, Canada, Germany, United Kingdom, France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa
Key Segments Covered Test Type, End User, Region
Key Companies Profiled Balanceback; DIFRA; BioMed Jena; Vesticon, Inc; Recorders & Medicare Systems; TECHNO CONCEPT; Interacoustics; BeOn Solutions; Homoth Medizinelektronik GmbH & Co.; Ecleris S.R.L; Micromedical Technologies; Natus Medical Incorporated; Otometrics A/S; Happersberger Otopront GmbH
Report Coverage Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing Available upon Request

Vestibular Testing System Market by Solution

By Test Type:

  • Videonystagmography (VNG)
  • Vestibular-evoked myogenic potential (VEMP)
  • Rotary chair
  • Computerized Dynamic Posturography
  • Others

By End User:

  • Hospitals
  • Diagnostic Centers
  • Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia & Pacific
  • East Asia
  • The Middle East & Africa (MEA)

Frequently Asked Questions

Which are the Key Countries in the Test and Measurement Sensors Market?

The United States, Japan, China, and India dominate the global market.

What is the Current Market Valuation?

The market is estimated to secure a valuation of US$ 119.3 million in 2023.

How Big will the Vestibular Testing System Market by 2033?

The market is estimated to reach US$ 202.4 million by 2033.

Which End User Holds Lucrative Opportunities?

The hospital segment holds high revenue potential.

Which Countries Dominate the Global Market?

The United States, the United Kingdom, and China dominate the global market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Test Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Test Type, 2023 to 2033

        5.3.1. Videonystagmography (VNG)

        5.3.2. Vestibular evoked myogenic potential (VEMP)

        5.3.3. Rotary chair

        5.3.4. Computerized dynamic posturography

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Diagnostic Centers

        6.3.3. Clinics

    6.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Test Type

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Test Type

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Test Type

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Test Type

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. United Kingdom

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Test Type

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Test Type

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Test Type

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Test Type

        11.3.3. By End User

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Test Type

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Test Type

        12.3.3. By End User

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Test Type

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Test Type

        13.3.3. By End User

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Test Type

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Test Type

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Test Type

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Test Type

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Test Type

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Test Type

            15.4.2.2. By End User

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Test Type

            15.5.2.2. By End User

    15.6. United Kingdom

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Test Type

            15.6.2.2. By End User

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Test Type

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Test Type

            15.8.2.2. By End User

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Test Type

            15.9.2.2. By End User

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Test Type

            15.10.2.2. By End User

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Test Type

            15.11.2.2. By End User

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Test Type

            15.12.2.2. By End User

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Test Type

            15.13.2.2. By End User

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Test Type

            15.14.2.2. By End User

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Test Type

            15.15.2.2. By End User

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Test Type

            15.16.2.2. By End User

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Test Type

            15.17.2.2. By End User

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Test Type

            15.18.2.2. By End User

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Test Type

            15.19.2.2. By End User

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Test Type

            15.20.2.2. By End User

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Test Type

            15.21.2.2. By End User

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Test Type

            15.22.2.2. By End User

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Test Type

            15.23.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Test Type

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Balanceback

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. DIFRA

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. BioMed Jena

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Vesticon, Inc

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Recorders & Medicare Systems

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. TECHNO CONCEPT

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Interacoustics

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. BeOn Solutions

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Homoth Medizinelektronik GmbH & Co.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. Ecleris S.R.L

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. Micromedical Technologies

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

        17.1.12. Natus Medical Incorporated

            17.1.12.1. Overview

            17.1.12.2. Product Portfolio

            17.1.12.3. Profitability by Market Segments

            17.1.12.4. Sales Footprint

            17.1.12.5. Strategy Overview

                17.1.12.5.1. Marketing Strategy

                17.1.12.5.2. Product Strategy

                17.1.12.5.3. Channel Strategy

        17.1.13. Otometrics A/S

            17.1.13.1. Overview

            17.1.13.2. Product Portfolio

            17.1.13.3. Profitability by Market Segments

            17.1.13.4. Sales Footprint

            17.1.13.5. Strategy Overview

                17.1.13.5.1. Marketing Strategy

                17.1.13.5.2. Product Strategy

                17.1.13.5.3. Channel Strategy

        17.1.14. Happersberger Otopront GmbH

            17.1.14.1. Overview

            17.1.14.2. Product Portfolio

            17.1.14.3. Profitability by Market Segments

            17.1.14.4. Sales Footprint

            17.1.14.5. Strategy Overview

                17.1.14.5.1. Marketing Strategy

                17.1.14.5.2. Product Strategy

                17.1.14.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Brain Imaging And Neuroimaging Market

September 2016

REP-GB-1841

July 2023

319 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Vestibular Testing System Market